Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-124044
Filing Date
2024-11-08
Accepted
2024-11-08 16:04:06
Documents
65
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q onvo-20240930.htm   iXBRL 10-Q 1999452
2 EX-31.1 onvo-ex31_1.htm EX-31.1 12436
3 EX-31.2 onvo-ex31_2.htm EX-31.2 12395
4 EX-32.1 onvo-ex32_1.htm EX-32.1 10419
  Complete submission text file 0000950170-24-124044.txt   7918676

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT onvo-20240930.xsd EX-101.SCH 1150785
68 EXTRACTED XBRL INSTANCE DOCUMENT onvo-20240930_htm.xml XML 1280969
Mailing Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121
Business Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121 858-224-1000
ORGANOVO HOLDINGS, INC. (Filer) CIK: 0001497253 (see all company filings)

EIN.: 271488943 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-35996 | Film No.: 241440426
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)